CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-22 | Benathen Marc David Chief Financial Officer | Grant or award | +87,000 | 426,554 | ||
| 2025-06-17 | Benathen Marc David Chief Financial Officer | Sale 10b5-1 | −50,000 | $14.01 | $700K | 339,554 |
| 2025-06-16 | Benathen Marc David Chief Financial Officer | Sale 10b5-1 | −75,000 | $13.09 | $982K | 389,554 |
| 2025-03-31 | Benathen Marc David Chief Financial Officer | Grant or award | +75,000 | 464,554 | ||
| 2025-03-07 | Benathen Marc David Chief Financial Officer | Grant or award | +87,000 | 389,554 | ||
| 2024-03-21 | Benathen Marc David Chief Financial Officer | Grant or award | +75,000 | 302,554 | ||
| 2023-07-11 | Benathen Marc David Chief Financial Officer | Grant or award | +125,000 | 202,554 | ||
| 2023-07-11 | Benathen Marc David Chief Financial Officer | Exercise or conversion | +25,000 | 227,554 | ||
| 2023-07-11 | Benathen Marc David Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2023-07-11 | Benathen Marc David Chief Financial Officer | Exercise or conversion · Restricted Stock | −25,000 | 0 | ||
| 2023-01-27 | Benathen Marc David Chief Financial Officer | Exercise or conversion | +25,000 | 77,554 | ||
| 2023-01-27 | Benathen Marc David Chief Financial Officer | Exercise or conversion · Restricted Stock | −25,000 | 25,000 | ||
| 2022-01-27 | Benathen Marc David Chief Financial Officer | Exercise or conversion | +25,000 | 52,554 | ||
| 2022-01-27 | Benathen Marc David Chief Financial Officer | Grant or award · Restricted Stock Unit | +75,000 | 75,000 | ||
| 2022-01-27 | Benathen Marc David Chief Financial Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 50,000 | ||
| 2021-11-30 | Benathen Marc David Chief Financial Officer | Purchase | +7,831 | $4.09 | $32K | 27,554 |
| 2021-08-18 | Benathen Marc David Chief Financial Officer | Purchase | +1,297 | $7.23 | $9K | 17,953 |
| 2021-08-18 | Benathen Marc David Chief Financial Officer | Purchase | +1,300 | $7.26 | $9K | 19,253 |
| 2021-08-18 | Benathen Marc David Chief Financial Officer | Purchase | +64 | $7.29 | $467 | 19,317 |
| 2021-08-18 | Benathen Marc David Chief Financial Officer | Purchase | +63 | $7.24 | $456 | 19,380 |
Page 1 of 2 · 23 trades